Sees FY26 adjusted EBITDA $35M-$45M. The company said, “BeautyHealth enters 2026 with a strong foundation – a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus now is to unlock the full economic potential of our platform by strengthening commercial execution, expanding utilization, improving provider economics, and investing in clinically meaningful innovation.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKIN:
- Beauty Health reports Q4 EPS (6c) vs. (8c) last year
- Beauty Health sees Q1 revenue $63M-$68M, consensus $68.19M
- SKIN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Beauty Health announces ‘growing adoption’ of SkinStylus Nano-Channeling
- Beauty Health Advances Governance Settlement Over Syndeo Launch